Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
ACS Pharmacology & Translational Science|June 19, 2025
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic DysfunctionPerihan A Elzahhar, Hisham A Nematalla, Malak A Abouayana, et al.
Journal of Medicinal Chemistry|June 25, 2024
Development of a Potent and Selective G2A (GPR132) AgonistVictor Hernandez-Olmos, Jan Heering, Beatrice Marinescu, et al.
Reviews of Geophysics (Washington, D.C. : 1985)|August 28, 2018
Remote Sensing of Droplet Number Concentration in Warm Clouds: A Review of the Current State of Knowledge and PerspectivesDaniel P Grosvenor, Odran Sourdeval, Paquita Zuidema, et al.
RSC Medicinal Chemistry|December 2, 2024
Toward target 2035: EUbOPEN - a public-private partnership to enable & unlock biology in the openClaudia Tredup, Suzanne Ackloo, Hartmut Beck, et al.
RSC Medicinal Chemistry|February 25, 2022
Target 2035 - update on the quest for a probe for every proteinSusanne Müller, Suzanne Ackloo, Arij Al Chawaf, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
ACS Pharmacology & Translational Science|June 19, 2025
Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic DysfunctionPerihan A Elzahhar, Hisham A Nematalla, Malak A Abouayana, et al.
Journal of Medicinal Chemistry|June 25, 2024
Development of a Potent and Selective G2A (GPR132) AgonistVictor Hernandez-Olmos, Jan Heering, Beatrice Marinescu, et al.
Reviews of Geophysics (Washington, D.C. : 1985)|August 28, 2018
Remote Sensing of Droplet Number Concentration in Warm Clouds: A Review of the Current State of Knowledge and PerspectivesDaniel P Grosvenor, Odran Sourdeval, Paquita Zuidema, et al.
RSC Medicinal Chemistry|December 2, 2024
Toward target 2035: EUbOPEN - a public-private partnership to enable & unlock biology in the openClaudia Tredup, Suzanne Ackloo, Hartmut Beck, et al.
RSC Medicinal Chemistry|February 25, 2022
Target 2035 - update on the quest for a probe for every proteinSusanne Müller, Suzanne Ackloo, Arij Al Chawaf, et al.
Pageof 17